Skip to main content

Table 2 Genes differentially up- or downregulated in SVR in IL28B CC and IL28T* cohorts over the course of the treatment period (P < 0.05).

From: The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin

Alelle Day 0 Day 1 Day 7 Day 28 Day 56
  Up Down Up Down Up Down Up Down Up Down
IL28B CC   None      ATP6V0B    BST2
  IL1B
IRF2
NFKB2
PRDM1
SOCS1
  CCL4
IFITM1
SSBP1
LIPA
PRKRA
ADAR
ATP6V0B
BTG1
CCL3
CCL4
CREB1
ICAM1
IKBKG
IRF1
LYN
PLAUR
PRKRIR
RNASEL
SOCS1
STAT3
STAT6
TAP2
FYN
IRF3
EIF2AK2
FAS
GBP1
GTPBP2
IFI35
IFI44
IFI44L
IFIT1
IFIT2
IFIT5
IFITM3
IRF7
SELL
SP110
TAP2
TRIM34
DHX9
FYN
IRF3
LIPA
IFITM3 CD81
FYN
IKBKB
IRF3
MX1
PSME2
TRIM14
TRIM26
TRIM34
IL28B T* AIM2
IKBKE
IRF2
LCK
SOCS1
STAT6 IRF2
LCK
TRAF6
NMI
YARS
BTG1
CREB1
FAS
GMPR
HIF1A
IFNAR1
IRF2
SELL
SOCS1
TAP1
TGFB1
TRADD
TRAF6
IL10
SHFM1
YARS
IFNAR1 NMI
PRKRA
CREB1 CTLA4
IFI30
IRF5